Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Mar;91 Suppl 1(Suppl 1):S16-22.
doi: 10.1002/bdra.20776. Epub 2011 Mar 4.

Paper 2: EUROCAT public health indicators for congenital anomalies in Europe

Babak Khoshnood  1 , Ruth Greenlees, Maria Loane, Helen Dolk; EUROCAT Project Management Committee; EUROCAT Working Group
Collaborators, Affiliations
Review

Paper 2: EUROCAT public health indicators for congenital anomalies in Europe

Babak Khoshnood et al. Birth Defects Res A Clin Mol Teratol. 2011 Mar.

Abstract

Objective: The purpose of this article is to present the specific public health indicators recently developed by EUROCAT that aim to summarize important aspects of the public health impact of congenital anomalies in a few quantitative measures.

Methods: The six indicators are: (1) congenital anomaly perinatal mortality, (2) congenital anomaly prenatal diagnosis prevalence, (3) congenital anomaly termination of pregnancy, (4) Down syndrome livebirth prevalence, (5) congenital anomaly pediatric surgery, and (6) neural tube defects (NTD) total prevalence. Data presented for this report pertained to all cases (livebirths, fetal deaths, or stillbirths after 20 weeks of gestation and terminations of pregnancy for fetal anomaly [TOPFA]) of congenital anomaly from 27 full member registries of EUROCAT that could provide data for at least 3 years during the period 2004 to 2008. Prevalence of anomalies, prenatal diagnosis, TOPFA, pediatric surgery, and perinatal mortality were calculated per 1000 births.

Results: The overall perinatal mortality was approximately 1.0 per 1000 births for EUROCAT registries with almost half due to fetal and the other half due to first week deaths. There were wide variations in perinatal mortality across the registries with the highest rates observed in Dublin and Malta, registries in countries where TOPFA are illegal, and in Ukraine. The overall perinatal mortality across EUROCAT registries slightly decreased between 2004 and 2008 due to a decrease in first week deaths. The prevalence of TOPFA was fairly stable at about 4 per 1000 births. There were variations in livebirth prevalence of cases typically requiring surgery across the registries; however, for most registries this prevalence was between 3 and 5 per 1000 births. Prevalence of NTD decreased by about 10% from 1.05 in 2004 to 0.94 per 1000 in 2008.

Conclusion: It is hoped that by publishing the data on EUROCAT indicators, the public health importance of congenital anomalies can be clearly summarized to policy makers, the need for accurate data from registries emphasized, the need for primary prevention and treatment services highlighted, and the impact of current services measured.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Perinatal mortality (foetal deaths (FD) + 1st week deaths) per 1000 births, EUROCAT Registries, 2004 – 2008
Figure 1
Figure 1
Perinatal mortality (foetal deaths (FD) + 1st week deaths) per 1000 births, EUROCAT Registries, 2004 – 2008
Figure 2
Figure 2
Prevalence of prenatal diagnosis per 1,000 births, EUROCAT Registries, 2004 – 2008
Figure 2
Figure 2
Prevalence of prenatal diagnosis per 1,000 births, EUROCAT Registries, 2004 – 2008
Figure 3
Figure 3
Prevalence of termination of pregnancy for foetal anomaly (TOPFA) per 1,000 births, EUROCAT Registries, 2004 – 2008
Figure 3
Figure 3
Prevalence of termination of pregnancy for foetal anomaly (TOPFA) per 1,000 births, EUROCAT Registries, 2004 – 2008
Figure 4
Figure 4
Live birth prevalence of Down syndrome per 1000 births, EUROCAT Registries, 2004 – 2008
Figure 5
Figure 5
Prevalence of six malformations and/or malformation groups typically requiring surgery per 1000 births, EUROCAT Registries, 2004 – 2008
Figure 5
Figure 5
Prevalence of six malformations and/or malformation groups typically requiring surgery per 1000 births, EUROCAT Registries, 2004 – 2008
Figure 6
Figure 6
Prevalence of neural tube defects (NTD) per 1000 births, EUROCAT Registries, 2004 – 2008
Figure 6
Figure 6
Prevalence of neural tube defects (NTD) per 1000 births, EUROCAT Registries, 2004 – 2008
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

  • The Safety of Second-Generation Antipsychotics During Pregnancy: A Clinically Focused Review.
    Damkier P, Videbech P. Damkier P, et al. CNS Drugs. 2018 Apr;32(4):351-366. doi: 10.1007/s40263-018-0517-5. CNS Drugs. 2018. PMID: 29637530 Review.
  • Long term trends in prevalence of neural tube defects in Europe: population based study.
    Khoshnood B, Loane M, de Walle H, Arriola L, Addor MC, Barisic I, Beres J, Bianchi F, Dias C, Draper E, Garne E, Gatt M, Haeusler M, Klungsoyr K, Latos-Bielenska A, Lynch C, McDonnell B, Nelen V, Neville AJ, O'Mahony MT, Queisser-Luft A, Rankin J, Rissmann A, Ritvanen A, Rounding C, Sipek A, Tucker D, Verellen-Dumoulin C, Wellesley D, Dolk H. Khoshnood B, et al. BMJ. 2015 Nov 24;351:h5949. doi: 10.1136/bmj.h5949. BMJ. 2015. PMID: 26601850 Free PMC article.
  • Genetic dissection of the Down syndrome critical region.
    Jiang X, Liu C, Yu T, Zhang L, Meng K, Xing Z, Belichenko PV, Kleschevnikov AM, Pao A, Peresie J, Wie S, Mobley WC, Yu YE. Jiang X, et al. Hum Mol Genet. 2015 Nov 15;24(22):6540-51. doi: 10.1093/hmg/ddv364. Epub 2015 Sep 15. Hum Mol Genet. 2015. PMID: 26374847 Free PMC article.
  • Rodent models in Down syndrome research: impact and future opportunities.
    Herault Y, Delabar JM, Fisher EMC, Tybulewicz VLJ, Yu E, Brault V. Herault Y, et al. Dis Model Mech. 2017 Oct 1;10(10):1165-1186. doi: 10.1242/dmm.029728. Dis Model Mech. 2017. PMID: 28993310 Free PMC article. Review.
  • Prevalence of congenital heart defects in Europe, 2008-2015: A registry-based study.
    Mamasoula C, Addor MC, Carbonell CC, Dias CM, Echevarría-González-de-Garibay LJ, Gatt M, Khoshnood B, Klungsoyr K, Randall K, Stoianova S, Haeusler M, Nelen V, Neville AJ, Perthus I, Pierini A, Bertaut-Nativel B, Rissmann A, Rouget F, Schaub B, Tucker D, Wellesley D, Zymak-Zakutnia N, Barisic I, de Walle HEK, Lanzoni M, Mullaney C, Pennington L, Rankin J. Mamasoula C, et al. Birth Defects Res. 2022 Dec 1;114(20):1404-1416. doi: 10.1002/bdr2.2117. Epub 2022 Nov 8. Birth Defects Res. 2022. PMID: 36345679 Free PMC article.
See all "Cited by" articles

References

    1. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349:1436–1442. - PubMed
    1. de Hollander AE, Melse JM, Lebret E, Kramers PG. An aggregate public health indicator to represent the impact of multiple environmental exposures. Epidemiology. 1999;10:606–617. - PubMed
    1. Ezzati M, Lopez AD, Rodgers A, Vander HS, Murray CJ. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360:1347–1360. - PubMed
    1. Rare Diseases Task Force Working Group on Health Indicators. Health indicators for rare diseases: Conceptual framework and development of indicators from existing sources. 2010. http://www.eucerd.eu/upload/file/RDTFReportIndicatorsApril2010.pdf.
    1. Bonnet D, Coltri A, Butera G, et al. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation. 1999;99:916–918. - PubMed

Publication types